SANDMAN PAUL W 4
4 · PDL BIOPHARMA, INC. · Filed Apr 9, 2009
Insider Transaction Report
Form 4
SANDMAN PAUL W
Director
Transactions
- Purchase
Common Stock
2009-04-08$7.38/sh+10,000$73,822→ 52,500 total
Footnotes (1)
- [F1]This transaction was executed in multiple trades at prices ranging from $7.35 to $7.40. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.